Ticker
ABOS

Price
5.47
Stock movement up
+0.43 (8.53%)
Company name
Acumen Pharmaceuticals Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Market cap
221.54M
Ent value
116.78M
Price/Sales
-
Price/Book
1.03
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
-67.94%
3 year return
-
5 year return
-
10 year return
-
Last updated: 2022-08-25

DIVIDENDS

ABOS does not pay dividends

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales-
Price to Book1.03
EV to Sales-

FINANCIALS

Per share

Loading...
Per share data
Current share count40.50M
EPS (TTM)-2.16
FCF per share (TTM)-0.63

Income statement

Loading...
Income statement data
Revenue (TTM)0.00
Gross profit (TTM)0.00
Operating income (TTM)-25.00M
Net income (TTM)-82.74M
EPS (TTM)-2.16
EPS (1y forward)-1.18

Margins

Loading...
Margins data
Gross margin (TTM)-
Operating margin (TTM)-
Profit margin (TTM)-

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash108.76M
Net receivables158.00K
Total current assets192.10M
Goodwill0.00
Intangible assets0.00
Property, plant and equipment0.00
Total assets220.09M
Accounts payable1.22M
Short/Current long term debt201.00K
Total current liabilities3.94M
Total liabilities4.00M
Shareholder's equity216.09M
Net tangible assets216.09M

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-23.89M
Capital expenditures (TTM)55.00K
Free cash flow (TTM)-23.95M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-38.29%
Return on Assets-37.59%
Return on Invested Capital-38.26%
Cash Return on Invested Capital-11.07%

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open5.13
Daily high5.57
Daily low5.12
Daily Volume31K
All-time high20.28
1y analyst estimate16.67
Beta-
EPS (TTM)-2.16
Dividend per share-
Ex-div date-
Next earnings date-

Downside potential

Loading...
Downside potential data
ABOSS&P500
Current price drop from All-time high-73.03%-13.41%
Highest price drop-84.81%-56.47%
Date of highest drop11 May 20229 Mar 2009
Avg drop from high-56.88%-11.38%
Avg time to new high290 days12 days
Max time to new high289 days1805 days
COMPANY DETAILS
ABOS (Acumen Pharmaceuticals Inc) company logo
Marketcap
221.54M
Marketcap category
Small-cap
Description
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia.
Employees
14
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found